|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
5/1/2012 10:20:52 AM
MONTREAL--(BUSINESS WIRE)--Sonomax Technologies Inc. (“Sonomax” or the “Company”) (TSX Venture: SHH) today disclosed its results for the year ended December 31, 2011. In order to get SonoFit™ adopted by OEMs, Sonomax needed to accomplish three important milestones in 2011. First, we needed to complete the product development for eers™ and SonoFit™. Second, establish low cost offshore manufacturing for both eers™ and SonoFit™. Finally, the company had to demonstrate that sales could be made for eers™ and that returns would be below 5%. We are happy to report that we achieved all 3 milestones and the result is the Altec Lansing agreement (http://www.businesswire.ca/news/ca-en/20120418005833/en/Sonomax%C2%AE-Signs-Material-OEM-Agreement-Leading-Audio) which promises to be the first in a series of OEM agreements to be announced over the next 12 months in the various vertical markets of Consumer Electronics, Industrial, Military and Health. The result of this development was a loss of $5,191,081 compared to $4,167,792 in 2010. Gross loss was $230,090 in 2011 compared to gross profit of $31,637 in 2010. Management is happy to report that the bulk of this work is now behind us.
|
|
|
|
|
|
|
|
|
|
|